Sort
50,496 grants matching “lung cancer”
DEVELOPMENTAL FUNDS
$689,820Herbert Kim Lyerly · Duke University · P30 · FY2009 · CA
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells
$689,820David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Phase II Clinical Trial of Polyphenon E in Prostate Cancer
$689,729Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Imaging Activated Macrophages in the Lungs
$689,714Timothy S Blackwell · Vanderbilt University Medical Center · R01 · FY2016 · HL
Integrating Tobacco Treatment into Cancer Care
$689,597Elyse R Park · Massachusetts General Hospital · R01 · FY2015 · CA
The Thromboxane-Prostanoid Receptor in Radiation-Induced Pulmonary Fibrosis
$689,596James D West · Vanderbilt University Medical Center · R01 · FY2024 · CA
Urban and Reservation Implementation of All Nations Breath of Life to Improve Smoking Cessation Rates among American Indians
$689,574Christine Makosky Daley · University Of Kansas Medical Center · R01 · FY2019 · DA
Rapid Automated High-Throughput Radiation Biodosimetry
$689,494David Jonathan Brenner · Columbia University Health Sciences · U19 · FY2017 · AI
Genetic evolution of glioblastomas during radiation and temozolomide therapy
$689,449Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
$689,368Dejana K Braithwaite · Georgetown University · R01 · FY2020 · CA
Sex/Gender and Nicotine Addiction: Hormones, Behavior and Neuroimaging
$689,364Nancy K. Mello · Mclean Hospital · R01 · FY2010 · DA
Culturally and Linguistically Adapted Physical Activity Intervention for Latinas
$689,360Bess Hya Marcus · Brown University · R01 · FY2010 · NR
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
$689,321Jane Amanda Skok · New York University School Of Medicine · R01 · FY2023 · CA
Sex/Gender and Nicotine Addiction: Hormones, Behavior and Neuroimaging
$689,145Scott E Lukas · Mclean Hospital · R01 · FY2014 · DA
Rhesus HHV-8 homologue in AIDS-related malignancies
$689,049Scott W Wong · Oregon Health & Science University · R01 · FY2012 · CA
Physical Activity, Sedentary Behavior, and Cancer Incidence in Women
$688,906Kelly Evenson · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Clinical trials employing cancer vaccine combination therapies
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Phase II Clinical Trial of Polyphenon E in Prostate Cancer
$688,824Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$688,740Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Functional consequences of cancer mutations
$688,494Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Optimizing Lung Cancer Screening in Cancer Survivors
$688,469Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Enabling Ultra Low Dose PET/CT Imaging
$688,444Paul E Kinahan · University Of Washington · R01 · FY2015 · CA
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (3 of 3)
$688,440Baqar A Husaini · Tennessee State University · U54 · FY2013 · CA
Special Mouse Strains Resource
$688,372Leah Rae B Donahue · Jackson Laboratory · P40 · FY2009 · RR